Country Aspect of Medicine:

Pharmaceutical industry in Bangladesh has progressed well over the last 3 decades and the country is nearly self-sufficient in pharmaceuticals production with 97% of its demand being met by domestic manufacturers. Since the promulgation of Drug Policy in 1982, the sector has grown from about $20 million to almost $2 billion today. Bangladeshi medicines are being exported to many countries in the world and leading players are making forays into the most regulated markets of Europe, US and Australia. And very importantly, WTO/TRIPS allows Bangladesh to enjoy the pharma patent waiver which has been recently extended for another 17 years until 2033.